Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

For many this will be their fifth year of getting Covid vaccines – and some will ask if it is still worth getting the jab.

The case stems from a Leawood woman who sought a religious exemption from the COVID-19 vaccine requirement for an ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Pakistan's President Asif Ali Zardari, age 69, has tested positive for COVID and is currently in isolation. After ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

An outbreak within a person’s own community appears to be one of the most potent influences on Americans’ vaccination decisions.

Imposing a vaccine mandate for staff at all nursing homes shortly after COVID shots became available may have saved nearly 10,000 lives.

Experts say LP.8.1’s symptoms align with those of other circulating strains, showing no heightened severity, suggesting it ...

The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...

More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants of the ...